Early clinical trials suggest the drug MDMA, also known as Ecstasy, may be beneficial in treating and even curing Post Traumatic Stress Disorder.

The research protocol used in the MAPS studies uses a male-female team of therapists working with each patient. It is an expensive and labor intensive approach, but Executive Director Rick  Doblin says there are several sound reasons for proceeding that way.